EQUINE THYMOCYTE IMMUNE GLOBULIN: 763 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Drug Class: Antibody-Surface Protein Interactions [MoA] · Route: ORAL · Manufacturer: Uriel Pharmacy Inc. · HUMAN OTC DRUG · FDA Label: Available
First Report: 1982 · Latest Report: 20250922
What Are the Most Common EQUINE THYMOCYTE IMMUNE GLOBULIN Side Effects?
All EQUINE THYMOCYTE IMMUNE GLOBULIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Transplant rejection | 100 | 13.1% | 1 | 1 |
| Alopecia | 98 | 12.8% | 0 | 0 |
| Acne | 97 | 12.7% | 0 | 0 |
| Transplant dysfunction | 97 | 12.7% | 0 | 0 |
| Ovarian cyst | 96 | 12.6% | 0 | 0 |
| Drug ineffective | 89 | 11.7% | 23 | 19 |
| Pyrexia | 69 | 9.0% | 14 | 33 |
| Acute kidney injury | 58 | 7.6% | 9 | 24 |
| Condition aggravated | 55 | 7.2% | 2 | 4 |
| Product use in unapproved indication | 55 | 7.2% | 12 | 13 |
| Off label use | 54 | 7.1% | 10 | 12 |
| Pain | 54 | 7.1% | 4 | 5 |
| Pneumonia | 51 | 6.7% | 1 | 3 |
| Liver function test abnormal | 48 | 6.3% | 1 | 1 |
| Hypertension | 45 | 5.9% | 7 | 16 |
| Rheumatoid arthritis | 44 | 5.8% | 0 | 0 |
| Sleep disorder due to general medical condition, insomnia type | 44 | 5.8% | 0 | 0 |
| Product use issue | 36 | 4.7% | 4 | 3 |
| Septic shock | 34 | 4.5% | 24 | 23 |
| Sepsis | 30 | 3.9% | 13 | 19 |
Who Reports EQUINE THYMOCYTE IMMUNE GLOBULIN Side Effects? Age & Gender Data
Gender: 62.2% female, 37.8% male. Average age: 41.0 years. Most reports from: CA. View detailed demographics →
Is EQUINE THYMOCYTE IMMUNE GLOBULIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 1 | 1 | 1 |
| 2007 | 2 | 0 | 1 |
| 2011 | 1 | 0 | 0 |
| 2012 | 9 | 5 | 6 |
| 2013 | 27 | 8 | 15 |
| 2014 | 28 | 5 | 19 |
| 2015 | 16 | 6 | 3 |
| 2016 | 15 | 6 | 5 |
| 2017 | 17 | 3 | 11 |
| 2018 | 13 | 2 | 10 |
| 2019 | 31 | 6 | 14 |
| 2020 | 18 | 1 | 6 |
| 2021 | 26 | 2 | 7 |
| 2022 | 5 | 1 | 2 |
| 2023 | 30 | 6 | 8 |
| 2024 | 9 | 1 | 1 |
| 2025 | 8 | 0 | 2 |
What Is EQUINE THYMOCYTE IMMUNE GLOBULIN Used For?
EQUINE THYMOCYTE IMMUNE GLOBULIN vs Alternatives: Which Is Safer?
Other Drugs in Same Class: Antibody-Surface Protein Interactions [MoA]
Official FDA Label for EQUINE THYMOCYTE IMMUNE GLOBULIN
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
FOR ORAL USE ONLY
Dosage & Administration
Directions: Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow. Follow inside instructions to open ampule.
Warnings
Warnings: NOT FOR INJECTION Do not use if allergic to any ingredient. Consult a physician if symptoms worsen. If pregnant or nursing, consult a physician before use. Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Active Ingredient
Active Ingredient: Lymphocytes (Equine white blood cells) 6X
Inactive Ingredients
Inactive Ingredients: Water, Salt prepared using rhythmical processes